Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 5, 2025
Integrating administrative health data and machine learning to predict ALS onsetToni Mora, David Roche, Pol Andrés Benito, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 1, 2025
Spanish adaptation of the Primary Lateral Sclerosis Functional Rating Scale (PLSFRS)Alejandro Caravaca Puchades, Mònica Povedano Panadés, María Bea Sintes, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 1, 2025
Yentl syndrome, a real phenomenon in amyotrophic lateral sclerosis (ALS)?Saioa Fernández Soberón, Tatiana Gómez Escobar, Alejandro Caravaca Puchades, et al.
Multiple Sclerosis and Related Disorders|August 2, 2025
The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosisRaquel Tena-Cucala, Pablo Naval-Baudin, Antonio Martínez-Yélamos, et al.
Brain Pathology (Zurich, Switzerland)|March 4, 2026
Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survivalSergio Roca-Pereira, Yaiza López-Sampere, Pol Mengod-Soler, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALSRosario Vasta, Fouke Ombelet, Frederik Hobin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALSRobert McFarlane, Sarah Opie-Martin, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohortAlejandro Caravaca Puchades, Harry E McDonough, Ammar Al-Chalabi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS studyStefan Sennfält, Ammar Al-Chalabi, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALSHarry McDonough, Robert McFarlane, Alejandro Caravaca Puchades, et al.
Pageof 2